The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inactivation of p53 by high-risk E6, also downregulates angiogenic inhibitors, TSP-1 and maspin, while upregulating VEGF-inducing angiogenesis [293,294,295,296,297]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [297]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 3×
“The magnitude of an angiogenic response depends upon a complex set of interactions within the microenvironment (Coussens et al., 1999; Mueller and Fusenig, 2004; Zhu et al., 2002).”
Background
Research works printed but not linked: 30
- Arbeit, 1996, Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice, Oncogene, 13, 1847
- Bequet-Romero, 2000, Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins, Biochem. Biophys. Res. Commun., 277, 55, 10.1006/bbrc.2000.3628 · DOI
- Berger, 2006, Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras, Virology, 356, 68, 10.1016/j.virol.2006.07.039 · DOI
- Bhowmick, 2004, Stromal fibroblasts in cancer initiation and progression, Nature, 432, 332, 10.1038/nature03096 · DOI
- Bosch, 2002, The causal relation between human papillomavirus and cervical cancer, J. Clin. Pathol., 55, 244, 10.1136/jcp.55.4.244 · DOI
- Bouck, 1996, How tumors become angiogenic, Adv. Cancer Res., 69, 135, 10.1016/S0065-230X(08)60862-3 · DOI
- Butz, 2003, siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells, Oncogene, 22, 5938, 10.1038/sj.onc.1206894 · DOI · Paper page
- DeFilippis, 2003, Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells, J. Virol., 77, 1551, 10.1128/JVI.77.2.1551-1563.2003 · DOI
- Dobbs, 1997, Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia, Br. J. Cancer, 76, 1410, 10.1038/bjc.1997.571 · DOI
- Guidi, 1995, Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia, J. Natl. Cancer Inst., 87, 1237, 10.1093/jnci/87.16.1237 · DOI
- Hall, 2003, RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells, J. Virol., 77, 6066, 10.1128/JVI.77.10.6066-6069.2003 · DOI
- Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7 · DOI · Paper page
- Herrero, 2003, Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study, J. Natl. Cancer Inst., 95, 1772, 10.1093/jnci/djg107 · DOI
- Huang, 2002, Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF, J. Virol., 76, 8710, 10.1128/JVI.76.17.8710-8721.2002 · DOI · Paper page
- Jiang, 2002, Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference, Oncogene, 21, 6041, 10.1038/sj.onc.1205878 · DOI
- Kodama, 1999, Vascular endothelial growth factor is implicated in early invasion in cervical cancer, Eur. J. Cancer, 35, 485, 10.1016/S0959-8049(98)00410-9 · DOI
- Lingen, 1996, Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic, Am. J. Pathol., 149, 247
- Mueller, 2004, Friends or foes—Bipolar effects of the tumour stroma in cancer, Nat. Rev., Cancer, 4, 839, 10.1038/nrc1477 · DOI
- Munchhof, 2006, Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells, Hum. Mol. Genet., 15, 1858, 10.1093/hmg/ddl108 · DOI
- Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N. Engl. J. Med., 348, 518, 10.1056/NEJMoa021641 · DOI · Paper page
- Nees, 2001, Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes, J. Virol., 75, 4283, 10.1128/JVI.75.9.4283-4296.2001 · DOI
- Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, 121, 335, 10.1016/j.cell.2005.02.034 · DOI · Paper page
- Seo, 2004, Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation, Cancer Res., 64, 6482, 10.1158/0008-5472.CAN-03-2774 · DOI
- Smith, 1998, Human papillomavirus and risk of oral cancer, Laryngoscope, 108, 1098, 10.1097/00005537-199807000-00027 · DOI
- Smith-McCune, 1997, Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice, Cancer Res., 57, 1294
- Sprague, 2002, Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes, Virology, 301, 247, 10.1006/viro.2002.1542 · DOI
- Toussaint-Smith, 2004, Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors, Oncogene, 23, 2988, 10.1038/sj.onc.1207442 · DOI · Paper page
- Wu, 1982, The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia, Cell, 31, 693, 10.1016/0092-8674(82)90324-5 · DOI
- Zhu, 2002, Neurofibromas in NF1: Schwann cell origin and role of tumor environment, Science, 296, 920, 10.1126/science.1068452 · DOI
- zur Hausen, 2000, Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis, J. Natl. Cancer Inst., 92, 690, 10.1093/jnci/92.9.690 · DOI
Cited by
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Metadata
- Authors
- Chen, W., Li, F., Mead, L., White, H., Walker, J., Ingram, D. A., & Roman, A.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 367
- Issue
- 1
- Pages
- 168-174
- ISSN
- 0042-6822
- Cited by
- 43
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review